[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 43,318
Sort by:

2014-2018 French Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers

US$ 5,360.00

... , sales forecasts, supplier shares) $4,300. Emerging Opportunities in the French Virology and Bacteriology Testing Market is a new strategic analysis of major business ... market during the nextfive years. The report examines key French market trends; reviews current and emerging assays; analyzes potential ...

November 2014 890 pages

2014-2018 European Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 5,520.00

... , supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

November 2014 295 pages

2014-2018 European Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK

US$ 15,760.00

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Emerging Opportunities in the European Virology and Bacteriology Testing Market is a new five-countrystrategic analysis of major business opportunities emerging in the infectious disease testing market during the ...

November 2014 1600 pages

2014-2018 European Infectious Disease Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK

US$ 15,760.00

... volumes, sales forecasts, supplier shares) $12,800. 2014 Opportunities in the European Infectious Disease Testing Market is a new five-countrystrategic analysis of major ... Analysis Sales and market shares of major suppliers by individual test and country. Volume and sales forecasts for over 100 infectious ...

November 2014 1600 pages

2014-2018 World Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Japan, Spain, UK, US

US$ 26,000.00

Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Emerging Opportunities in the Global Virology and Bacteriology Testing Market is a new seven-countrystrategic analysis of major business opportunities emerging in the infectious disease testing market during the ...

November 2014 1900 pages

2014-2018 World Infectious Disease Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Japan, Spain, UK, US

US$ 26,000.00

... test volumes, sales forecasts, supplier shares) $21,100. 2014 Opportunities in the Global Infectious Disease Testing Market is a new seven-countrystrategic analysis of major ... main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise ...

November 2014 1900 pages

Physician Views: Reaction to Bristol-Myers Squibb's Opdivo data in non-small-cell lung cancer

US$ 695.00

... , were unveiled (ViewPoints: Investors respond in kind to impressive data for Bristol-Myers Squibb NSCLC immunotherapy). Checkmate-063 recruited 117 patients, each ... , noting that a 21 percent rate (or 18 percent for squamous patients) cited by Bristol-Myers Squibb stemmed from a database comprising only Medicare patients aged ...

November 2014

2014-2018 POC Lipid Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 3,480.00

... product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Rationale The growing economic pressures on ... opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years.- Design criteria for ...

November 2014 340 pages

2014-2018 US Hematology and Flow Cytometry Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

US$ 7,880.00

... of reagent and instrument suppliers. Instrumentation Review The study reviews current instrumentation technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. The report features analyzers manufactured by Abbott, Beckman Coulter/ ...

November 2014 275 pages

2014-2018 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers

US$ 3,080.00

This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. ...

November 2014 280 pages

2014-2018 Analysis of Molecular and Immunohematology Blood Banking Instrumentation, and Strategic Profiles of Leading Suppliers

US$ 3,080.00

This 111-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, ...

November 2014 111 pages

2014-2018 Analysis of Molecular and Immunohematology Blood Banking Technologies, and Strategic Profiles of Leading Suppliers

US$ 3,080.00

This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and ...

November 2014 154 pages

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

US$ 2,400.00

... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...

November 2014 573 pages

Global Non–Invasive Prenatal Testing Market, Test Volume & Forecast

US$ 1,400.00

... market for NIPT. Renub Research study titled “Global Non–Invasive Prenatal Testing Market, Test Volume & Forecast” explores a comprehensive assessment of the ... testing and different deals type in non–invasive prenatal testing market. All the 8 NIPT tests studied in the report are as follows 1. MaterniT21 ...

October 2014 67 pages

Medical Diagnostics Market in India 2014

US$ 950.00

... after order is placed. Netscribes’ latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which ...

October 2014 71 pages

In Vitro Diagnostics Market in India 2014

US$ 950.00

... placed. Netscribes’ latest market research report titled In Vitro Diagnostics Market in India 2014 analyses the growth of the market due to improved technology and ... modern diagnostic tools which ...

October 2014 128 pages

Competitor Analysis: Cardiovascular Peptides

US$ 383.00

Competitor Analysis: Cardiovascular Peptides The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the ...

October 2014 59 pages

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

US$ 2,400.00

... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...

October 2014 1400 pages

Global Cancer Kinase Inhibitors Market & Pipeline Insight

US$ 2,400.00

... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...

October 2014 1500 pages

Global Breast Cancer Vaccine Clinical Trial Insight

US$ 1,200.00

... Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: Global Breast Cancer Vaccine Market Overview Global Breast Cancer Vaccine Clinical Pipeline by Company, Phase & Country Mechanism of Breast Cancer Vaccine & Personalized Cancer Vaccines Detailed Clinical Insight on Breast Cancer Vaccine Pipeline ...

October 2014 134 pages

Latest Chinese Guidebook for Application and Approval of Imported In-Vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

US$ 1,495.00

... business smoothly in China. Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 ... reagents, from the basic principles of clinical trials, the clinical trial design, scheme and methods, the sample size of clinical trial ...

September 2014 208 pages

2014 Market Research Report on Global Blood Dialyzer Industry

US$ 2,850.00

'2014 Market Research Report on Global Blood Dialyzer Industry' was a professional and depth research report on Global Blood Dialyzer industry that you would ... , cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...

September 2014 176 pages

HbA1c Testing Market in India 2014

US$ 950.00

... in 0-2 business days after order is placed. Netscribes’ latest market research report titled HbA1c Testing Market in India 2014 states that with the increasing incidence of diabetes ...

September 2014 132 pages

Physician Views: The PD-1 inhibitor class lands – how do US oncologists expect to initially use Merck & Co.'s Keytruda?

US$ 695.00

... Yervoy (ipilimumab) and, if BRAF V600-mutation positive, a BRAF inhibitor (see also Physician Views Poll Results – Oncologists suggest Mekinist/Tafinlar combination will ... approval – the PD-1/PD-L1 inhibitors are expected to spearhead evolution of a multi-billion dollar market over the next decade – this Physician Views poll contains a second ...

September 2014

Physician Views: New data for Novartis' LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

US$ 695.00

... products, among the first in a new wave of medicines in late-stage development at Big Pharma for cardiovascular indications. Data from the PARADIGM-HF trial ... play a role in the company's price-setting calculus. Based on the new data, JP Morgan analyst Richard Vosser believes LCZ696 has 'multi-blockbuster ...

September 2014

Global Cancer Vaccines Market & Pipeline Analysis

US$ 2,400.00

... Cancer Vaccines Delivery Cancer Vaccines: Mechanism & Innovations Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for Cancer Vaccines Development & Marketing ...

September 2014 864 pages

Physician Views: When and where do oncologists see palbociclib fitting into the ER+, HER2- breast cancer landscape?

US$ 695.00

... 4/6 inhibitor class. Expectations for palbociclib were flying high in 2012 when Pfizer reported preliminary results from the Phase II PALOMA-1 trial showing the drug improved progression-free survival (PFS) by 18.6 months when added to Femara in postmenopausal women with oestrogen receptor (ER) positive, HER2 ...

August 2014

Future Horizons and Growth Strategies in the Alpha-2 Antiplasmin Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 195 pages and 8 tables

August 2014 195 pages

Future Horizons and Growth Strategies in the Antithrombin III Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 197 pages and 8 tables

August 2014 197 pages

Future Horizons and Growth Strategies in the D-Dimer Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 197 pages and 8 tables

August 2014 197 pages

Future Horizons and Growth Strategies in the Factor Assay Testing Market 2014: Country Forecasts

US$ 4,280.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 295 pages and 85 tables

August 2014 295 pages

Future Horizons and Growth Strategies in the Fibrinogen Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 tables

August 2014 200 pages

Future Horizons and Growth Strategies in the Heparin Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 tables

August 2014 200 pages

Future Horizons and Growth Strategies in the Proteins C and S Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 194 pages and 15 tables

August 2014 194 pages

Future Horizons and Growth Strategies in the PT Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 tables

August 2014 200 pages

Future Horizons and Growth Strategies in the Thrombin Time Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 196 pages and 8 tables

August 2014 196 pages

Future Horizons and Growth Strategies in the US Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 2,800.00

This new 236-page report from Venture Planning Group provides analysis of the US immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 236 pages

Future Horizons and Growth Strategies in the French Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the French immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 234 pages

Future Horizons and Growth Strategies in the German Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the German immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 236 pages

Future Horizons and Growth Strategies in the Italian Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 233-page report from Venture Planning Group provides analysis of the Italian immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 233 pages

Future Horizons and Growth Strategies in the Japanese Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 2,200.00

This new 234-page report from Venture Planning Group provides analysis of the Japanese immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 234 pages

Future Horizons and Growth Strategies in the Spanish Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the Spanish immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 236 pages

Future Horizons and Growth Strategies in the UK Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 234 pages

Future Horizons and Growth Strategies in the Home/Self Testing Market 2014

US$ 1,160.00

... new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.

August 2014 175 pages

Future Horizons and Growth Strategies in the US Home/Self Testing Market 2014

US$ 1,160.00

... new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.

August 2014 175 pages

In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020

US$ 4,500.00

... contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic ... competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. The ...

August 2014 239 pages

2014 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers

US$ 276,000.00

... has published a series of 10 global market research surveys, “2014 World In Vitro Diagnostics Industry:Market Shares and Country Forecasts.” ... Beckman Coulter/Danaher Becton Dickinson Bio/Data Biokit Biomedical Diagnostics Biomerieux Bio-Rad Biotest Caliper Cellavision Cephid Chrono-Log ...

August 2014 9700 pages

Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014

US$ 2,000.00

... trials studies have demonstrated the fact that the potential of peptide based drugs to prevent and eradicate cancer is far effective than conventional ... therapy, both conventional and peptide based cancer therapeutics are used for the treatment. “Global Peptide Cancer Therapeutics Market & Pipeline Insight ...

August 2014 556 pages

Global Cancer Generics Market Outlook 2018

US$ 1,400.00

... growth. According to our latest research report “Global Cancer Generics Market Outlook 2018”, the global oncology market touched a mark of US$ 91 Billion in 2013 ... future incidences, regional analysis and patent expiration status of key cancer drugs. Analysis of key industry trends and drivers crucial to the ...

July 2014 100 pages

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

US$ 3,900.00

... maintaining front line, product level access and education. In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord ... marketed and four pipeline products Examination of physicians’ current usage of Medical Affairs teams services Key findings regarding the most and ...

July 2014 54 pages

Filters

Search

Categories

675
84
1,065
33,609
152
69
819
657
1,866
4,252
70

Publishers

1
8
9
36
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
45
11
78
1
14
2
22
3
74
41,216
1
40
2
17
15
24
85
6
10
51
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
16,410
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

34
6
1
15
84